Proton pump inhibitor therapy predisposes to community-acquiredStreptococcus pneumoniaepneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proton pump inhibitor therapy predisposes to community-acquiredStreptococcus pneumoniaepneumonia

Published:2012-10-03 Issue:10 Volume:36 Page:941-949
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

de Jager C. P. C.¹,Wever P. C.²,Gemen E. F. A.³,van Oijen M. G. H.⁴,van Gageldonk-Lafeber A. B.⁵,Siersema P. D.⁴,Kusters G. C. M.³,Laheij R. J. F.

Affiliation:

1. Departments of Intensive Care and Emergency Medicine; ‘s-Hertogenbosch; The Netherlands

2. Medical Microbiology and Infection Control Jeroen Bosch Hospital; ‘s-Hertogenbosch; The Netherlands

3. Clinical Chemistry; ‘s-Hertogenbosch; The Netherlands

4. Department of Gastroenterology and Hepatology; University Medical Center Utrecht; Utrecht; The Netherlands

5. National Institute for Public Health and the Environment (RIVM); Centre for Infectious Disease Control; Bilthoven; The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12069/fullpdf

Reference37 articles.

1. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults;Mandell;Clin Infect Dis,2007

2. Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?;McCarthy;J Clin Gastroenterol,2012

3. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs;Laheij;JAMA,2004

4. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia;Johnstone;Aliment Pharmacol Ther,2010

5. Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials;Estborn;Drug Saf,2008

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manufacturing Process Development of Tegoprazan as a Potassium-Competitive Acid Blocker (P-CAB);Organic Process Research & Development;2024-03-08

2. Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database;Biological and Pharmaceutical Bulletin;2024-02-23

3. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study;Gut;2024-01-24

4. Gastric Acid Suppression Therapy and its Association with Peritoneal Dialysis-Associated Peritonitis in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS);Kidney360;2023-11-28

5. Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients;Renal Failure;2022-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3